114 related articles for article (PubMed ID: 17378926)
1. A retrospective nationwide case study on the use of a new antifungal agent: patients treated with caspofungin during 2001-2004 in Finland.
Anttila VJ; Salonen J; Ylipalosaari P; Koivula I; Riikonen P; Nikoskelainen J
Clin Microbiol Infect; 2007 Jun; 13(6):606-12. PubMed ID: 17378926
[TBL] [Abstract][Full Text] [Related]
2. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
Betts R; Glasmacher A; Maertens J; Maschmeyer G; Vazquez JA; Teppler H; Taylor A; Lupinacci R; Sable C; Kartsonis N
Cancer; 2006 Jan; 106(2):466-73. PubMed ID: 16353208
[TBL] [Abstract][Full Text] [Related]
4. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL
Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017
[TBL] [Abstract][Full Text] [Related]
5. Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.
Cesaro S; Giacchino M; Locatelli F; Spiller M; Buldini B; Castellini C; Caselli D; Giraldi E; Tucci F; Tridello G; Rossi MR; Castagnola E
BMC Infect Dis; 2007 Apr; 7():28. PubMed ID: 17442100
[TBL] [Abstract][Full Text] [Related]
7. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.
Candoni A; Mestroni R; Damiani D; Tiribelli M; Michelutti A; Silvestri F; Castelli M; Viale P; Fanin R
Eur J Haematol; 2005 Sep; 75(3):227-33. PubMed ID: 16104879
[TBL] [Abstract][Full Text] [Related]
8. An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy.
Ellis M; Frampton C; Joseph J; Alizadeh H; Kristensen J; Hauggaard A; Shammas F
J Med Microbiol; 2006 Oct; 55(Pt 10):1357-1365. PubMed ID: 17005784
[TBL] [Abstract][Full Text] [Related]
9. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.
Maertens J; Glasmacher A; Herbrecht R; Thiebaut A; Cordonnier C; Segal BH; Killar J; Taylor A; Kartsonis N; Patterson TF; Aoun M; Caillot D; Sable C;
Cancer; 2006 Dec; 107(12):2888-97. PubMed ID: 17103444
[TBL] [Abstract][Full Text] [Related]
10. Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study.
Kartsonis NA; Saah A; Lipka CJ; Taylor A; Sable CA
J Antimicrob Chemother; 2004 May; 53(5):878-81. PubMed ID: 15044431
[TBL] [Abstract][Full Text] [Related]
11. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
[TBL] [Abstract][Full Text] [Related]
12. A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.
Betts RF; Nucci M; Talwar D; Gareca M; Queiroz-Telles F; Bedimo RJ; Herbrecht R; Ruiz-Palacios G; Young JA; Baddley JW; Strohmaier KM; Tucker KA; Taylor AF; Kartsonis NA;
Clin Infect Dis; 2009 Jun; 48(12):1676-84. PubMed ID: 19419331
[TBL] [Abstract][Full Text] [Related]
13. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.
Lafaurie M; Lapalu J; Raffoux E; Breton B; Lacroix C; SociƩ G; Porcher R; Ribaud P; Touratier S; Molina JM
Clin Microbiol Infect; 2010 Aug; 16(8):1191-6. PubMed ID: 19735276
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin for the treatment of candidaemia in patients with haematological malignancies.
Pagano L; Fianchi L; Fanci R; Candoni A; Caira M; Posteraro B; Morselli M; Valentini CG; Farina G; Mitra ME; Offidani M; Sanguinetti M; Tosti ME; Nosari A; Leone G; Viale P
Clin Microbiol Infect; 2010 Mar; 16(3):298-301. PubMed ID: 19549221
[TBL] [Abstract][Full Text] [Related]
15. Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
Kartsonis NA; Saah AJ; Joy Lipka C; Taylor AF; Sable CA
J Infect; 2005 Apr; 50(3):196-205. PubMed ID: 15780413
[TBL] [Abstract][Full Text] [Related]
16. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
DiNubile MJ; Lupinacci RJ; Strohmaier KM; Sable CA; Kartsonis NA
J Crit Care; 2007 Sep; 22(3):237-44. PubMed ID: 17869975
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
Maertens J; Raad I; Petrikkos G; Boogaerts M; Selleslag D; Petersen FB; Sable CA; Kartsonis NA; Ngai A; Taylor A; Patterson TF; Denning DW; Walsh TJ;
Clin Infect Dis; 2004 Dec; 39(11):1563-71. PubMed ID: 15578352
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of caspofungin in obese patients.
Ryan DM; Lupinacci RJ; Kartsonis NA
Med Mycol; 2011 Oct; 49(7):748-54. PubMed ID: 21466264
[TBL] [Abstract][Full Text] [Related]
19. The use of caspofungin in HIV-infected individuals.
Waters L; Nelson M
Expert Opin Investig Drugs; 2007 Jun; 16(6):899-908. PubMed ID: 17501701
[TBL] [Abstract][Full Text] [Related]
20. Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study.
Winkler M; Pratschke J; Schulz U; Zheng S; Zhang M; Li W; Lu M; Sgarabotto D; Sganga G; Kaskel P; Chandwani S; Ma L; Petrovic J; Shivaprakash M
Transpl Infect Dis; 2010 Jun; 12(3):230-7. PubMed ID: 20070619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]